Mariëlle Kloosterman

QRS Area Is a Strong Determinant of Outcome in Cardiac Resynchronization Therapy

Antonius van Stipdonk, Iris ter Horst, Mariëlle Kloosterman et al. · Circulation Arrhythmia and Electrophysiology · 2018 · 114 citations · Full text

Medicine, Cardiology, Cardiac Transplantation +16

Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction

Bernadet T. Santema, Mariëlle Kloosterman, Isabelle C. Van Gelder et al. · European Heart Journal · 2018 · 65 citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +16

Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study

Mariëlle Kloosterman, Harry J.G.M. Crijns, Bart A. Mulder et al. · EP Europace · 2019 · 42 citations · Full text

Medicine, Cardiology, Men's Health +16

Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5

Mariëlle Kloosterman, Winnie Chua, Larissa Fabritz et al. · EP Europace · 2020 · 39 citations · Full text

Medicine, Cardiology, Interventional Cardiology +13

Reduction in the QRS area after cardiac resynchronization therapy is associated with survival and echocardiographic response

Mohammed A. Ghossein, Antonius van Stipdonk, Filip Plešinger et al. · Journal of Cardiovascular Electrophysiology · 2021 · 38 citations · Full text

Medicine, Cardiology, Cardiac Transplantation +11